Long-term survival, prevalence, and cure of cancer: A population-based estimation for 818 902 Italian patients and 26 cancer types

Annals of Oncology

Volumn 25, Issue 11, 2014, Pages 2251-2260

  Dal Maso, Luigino ^a   Guzzinati, S ^b   Buzzoni, C ^c,d   Capocaccia, R ^e   Serraino, D ^a   Caldarella, A ^d   Dei Tos, A P ^b,f   Falcini, F ^g   Autelitano, M ^h   Masanotti, G ⁱ   Ferretti, S ^j   Tisano, F ^k   Tirelli, U ^a   Crocetti, E ^d   De Angelis, R ^e   Virdone, S ^l   Zucchetto, A ^l   Gigli, A ^m   Francisci, S ^e   Baili, P ⁿ   Gatta, G ⁿ   Castaing, M ^o   Zanetti, R ^p   Contiero, P ⁿ   Bidoli, E ^q   Vercelli, M ^r   Michiara, M ^s   Federico, M ^t   Senatore, G ^u   Pannozzo, F ^v   Vicentini, M ^w   Bulatko, A ^x   Pirino, D R ^y   Gentilini, M ^z   Fusco, M ^aa   Giacomin, A ^ab   Fanetti, A C ^ac   Cusimano, R ^ad   more..

^a CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^b Occupational Health Unit   (Italy)

^c AIRTUM Database   (Italy)

^d Cancer Prevention and Research Institute ISPO   (Italy)

^e ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^f General Hospital of Treviso   (Italy)

^g Cancer Institute of Romagna   (Italy)

^h Milan Cancer Registry   (Italy)

ⁱ UNIVERSITY OF PERUGIA   (Italy)

^j UNIVERSITY OF FERRARA   (Italy)

^k ASP of Siracusa   (Italy)

^l CRO Aviano National Cancer Institute of Aviano   (Italy)

^m CNR   (Italy)

ⁿ NATIONAL CANCER INSTITUTE   (Italy)

^o National Cancer Institute of Milan ^*  (Italy)

^p CPO Centre for Epidemiology and Prevention in Oncology in Piedmont   (Italy)

^q Friuli Venezia Giulia Cancer Registry   (Italy)

^r Liguria Cancer Registry   (Italy)

^s PARMA CANCER REGISTRY   (Italy)

^t MODENA CANCER REGISTRY   (Italy)

^u Salerno Cancer Registry   (Italy)

^v Latina Cancer Registry   (Italy)

^w Reggio Emilia Cancer Registry   (Italy)

^x Alto Adige Sudtirol Cancer Registry   (Italy)

^y Sassari Cancer Registry   (Italy)

^z Osservatorio Epidemiologico   (Italy)

^aa Napoli Cancer Registry   (Italy)

^ab Biella Cancer Registry   (Italy)

^ac Sondrio Cancer Registry   (Italy)

^ad Palermo Breast Cancer Registry   (Italy)

more..

Author keywords

Cancer cure; Italy; Prevalence; Survival

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BRAIN CANCER; BREAST CANCER; CANCER SURVIVAL; COLON CANCER; FEMALE; HODGKIN DISEASE; HUMAN; ITALIAN (CITIZEN); LARYNX CANCER; LEUKEMIA; LIVER CANCER; LONG TERM SURVIVAL; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MYELOMA; PANCREAS CANCER; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; RECTUM CANCER; STOMACH CANCER; SURVIVAL TIME; TESTIS CANCER; THYROID CANCER; UTERINE CERVIX CANCER; DEMOGRAPHY; DISEASE FREE SURVIVAL; ETHNIC GROUP; ITALY; MIDDLE AGED; NEOPLASMS; PATHOLOGY;

ADOLESCENT; ADULT; AGED; DEMOGRAPHY; DISEASE-FREE SURVIVAL; ETHNIC GROUPS; FEMALE; HUMANS; ITALY; MALE; MIDDLE AGED; NEOPLASMS; PREVALENCE;

EID: 84922887415     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdu383     Document Type: Article

References (30)

1. AIRTUM Working Group. Italian cancer figures, report 2010. Cancer prevalence in Italy: Patients living with cancer, long-term survivors and cured patients. Epidemiol Prev 2010; 34(5-6 Suppl 2): 1-188. http://www.registri-tumori.it/cms/q=Rapp2010 (28 August 2014, date last accessed).
2. Parry C, Kent EE, Mariotto AB et al. Cancer survivors: a booming population. Cancer Epidemiol Biomarkers Prev 2011; 20: 1996-2005.
3. Gatta G, Mallone S, van der Zwan JM et al. Cancer prevalence estimates in Europe at the beginning of 2000. Ann Oncol 2013; 24: 1660-1666.
4. Coleman M, Quaresima M, Berrino F et al. Cancer Survival in five continents: a worldwide population-based study (CONCORD). Lancet Oncol 2008; 9: 730-756.
5. De Angelis R, Sant M, Coleman MP et al. Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE-5-a population-based study. Lancet Oncol 2014; 15: 23-34.
6. Francisci S, Capocaccia R, Grande E et al. The cure of cancer: a European perspective. Eur J Cancer 2009; 45: 1067-1079.
7. Baade PD, Youlden DR, Chambers SK. When do I know I am cured? Using conditional estimates to provide better information about cancer survival prospects. Med J Aust 2011; 194: 73-77. Erratum in Med J Aust 2011; 194: 376.
8. Ellison LF, Bryant H, Lockwood G, Shack L. Conditional survival analyses across cancer sites. Health Rep 2011; 22: 21-25.
9. McCabe MS, Bhatia S, Oeffinger KC et al. American society of Clinical Oncology Statement: achieving high-quality cancer survivorship care. J Clin Oncol 2013; 31: 631-640.
10. De Angelis R, Capocaccia R, Hakulinen T et al. Mixture models for cancer survival analysis: application to population-based data with covariates. Stat Med 1999; 18: 441-454.
11. Merrill RM, Capocaccia R, Feuer EJ, Mariotto A. Cancer prevalence estimates based on tumour registry data in the Surveillance, Epidemiology, and End Results (SEER) Program. Int J Epidemiol 2000; 29: 197-207.
12. Capocaccia R, De Angelis R. Estimating the completeness of prevalence based on cancer registry data. Stat Med 1997; 16: 425-440.
13. Janssen-Heijnen MLG, Gondos A, Bray F et al. Clinical relevance of conditional survival of cancer patients in Europe: age-specific analyses of 13 cancers. J Clin Oncol 2010; 28: 2520-2528.
14. Gatta G, Capocaccia R, Berrino F et al. Colon cancer prevalence and estimation of differing care needs of colon cancer patients. Ann Oncol 2004; 15: 1136-1142.
15. Smastuen M, Aagnes B, Johannsen TB et al. Long-term Cancer Survival: Patterns and Trends in Norway 1965-2007. Oslo: Cancer Registry of Norway 2008. http://www.kreftregisteret.no/Global/Publikasjoner%20og%20rapporter/CIN2007_del2.pdf (28 August 2014, date last accessed).
16. Janssen-Heijnen MLG, van Steenbergen LN, Voogd AC et al. Small but significant excess mortality compared with the general population for long-term survivors of breast cancer in the Netherlands. Ann Oncol 2014; 25: 64-68.
17. Woods LM, Rachet B, Lambert PC et al. 'Cure' from breast cancer among two populations of women followed for 23 years after diagnosis. Ann Oncol 2009; 20: 1331-1336.
18. Lambert PC, Dickman PW, Osterlund P et al. Temporal trends in the proportion cured for cancer of the colon and rectum: a population-based study using data from the Finnish Cancer Registry. Int J Cancer 2007; 121: 2052-2059.
19. Andrae B, Andersson TML, Lambert PC et al. Screening and cervical cancer cure: population based cohort study. Br Med J 2012; 344: e900.
20. Sinn M, Striefler JK, Sinn BV et al. Does long-term survival in patients with pancreatic cancer really exist? Results from the CONKO-001 study. J Surg Oncol 2013; 108: 398-402.
21. Cvancarova M, Aagnes B, Fosså SD et al. Proportion cured models applied to 23 cancer sites in Norway. Int J Cancer 2013; 132: 1700-1710.
22. Micheli A, Ciampichini R, Oberaigner W et al. The advantage of women in cancer survival: an analysis of EUROCARE-4 data. Eur J Cancer 2009; 45: 1017-1027.
23. Yu XQ, De Angelis R, Andersson TM et al. Estimating the proportion cured of cancer: some practical advice for users. Cancer Epidemiol 2013; 37: 836-842.
24. Othus M, Barlogie B, Leblanc ML, Crowley JJ. Cure models as a useful statistical tool for analyzing survival. Clin Cancer Res 2012; 18: 3731-3736.
25. Andersson TML, Lambert PC, Derolf AR et al. Temporal trends in the proportion cured among adults diagnosed with acute myeloid leukemia in Sweden 1973-2001: a population-based study. Br J Haematol 2009; 148: 918-924.
26. AIRTUM Working Group. Italian cancer figures, report 2011. Survival of cancer patients in Italy. Epidemiol Prev 2011; 35(Suppl3): 1-200. http://www.registritumori. it/cms/Rapp2011 (28 August 2014, date last accessed).
27. Early Breast Cancer Trialists' Collaborative Group (EBCTCG)Davies C, Godwin J et al. Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials. Lancet 2011; 378: 771-784.
28. Hinchliffe SR, Rutheford MJ, Crowter MJ et al. Should relative survival be used with lung cancer data. Br J Cancer 2012; 106: 1584-1589.
29. Baili P, Hoekstra-Weebers J, Van Hoof E et al. Cancer rehabilitation indicators for Europe. Eur J Cancer 2013; 49: 1356-1364.
30. De Moor JS, Mariotto AB, Parry C et al. Cancer survivors in the United States: prevalence across the survivorship trajectory and implication of care. Cancer Epidemiol Biomarkers Prev 2013; 22: 561-570.